MNMD vs GILD: Which Stock is Better?

Side-by-side comparison of Mind Medicine (Mindmed) Inc and Gilead Sciences Inc in 2026

Comparison Updated:

MNMD

Mind Medicine (Mindmed) Inc

$16.78

GILD

Gilead Sciences Inc

$124.14

Key Metrics Comparison

MetricMNMDGILDWinner
Market Cap$1.46B$154.99BGILD
P/E RatioN/A19.34GILD
EPS (TTM)$N/A$6.46GILD
Revenue Growth0.0%0.0%GILD
Gross Margin0.0%78.7%GILD

Analyze MNMD

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MNMD or GILD a better investment?

Comparing MNMD and GILD: Mind Medicine (Mindmed) Inc has a market cap of $1.46B while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MNMD and GILD?

MNMD (Mind Medicine (Mindmed) Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MNMD or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MNMD or GILD?

GILD has higher revenue growth at 0.0% vs 0.0% for MNMD.

Which company is more profitable: MNMD or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 0.0% for MNMD.

Which is the larger company: MNMD or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $1.46B for MNMD.

Should I buy MNMD or GILD in 2026?

Both MNMD and GILD have investment merit. MNMD trades at $16.78 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MNMD and GILD stock?

Key differences: Market Cap ($1.46B vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).

Popular Stock Comparisons